Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1843, Issue 5, 2014, Pages 976-984

  Fiorini, Claudia ^a   Gotte, Giovanni ^a   Donnarumma, Federica ^b   Picone, Delia ^b   Donadelli, Massimo ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Autophagy; Beclin1; BS RNase; Pancreatic cancer; RNase A; RNase oligomers

Indexed keywords

AUTOPHAGY; BECLIN1; BS-RNASE; PANCREATIC CANCER; RNASE A; RNASE OLIGOMERS;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CATTLE; CELL LINE, TUMOR; MALE; MEMBRANE PROTEINS; PANCREATIC NEOPLASMS; RIBONUCLEASE, PANCREATIC; SEMEN;

EID: 84894431891     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2014.01.025     Document Type: Article

References (61)

1. Burris H., Storniolo A.M. Assessing clinical benefit in the treatment of pancreas cancer: gemcitabine compared to 5-fluorouracil. Eur. J. Cancer 1997, 33(Suppl. 1):S18-S22.
2. Rosati A., Bersani S., Tavano F., Dalla Pozza E., De Marco M., Palmieri M., De Laurenzi V., Franco R., Scognamiglio G., Palaia R., Fontana A., di Sebastiano P., Donadelli M., Dando I., Medema J.P., Dijk F., Welling L., di Mola F.F., Pezzilli R., Turco M.C., Scarpa A. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Am. J. Pathol. 2012, 181:1524-1529.
3. Cecconi D., Palmieri M., Donadelli M. Proteomics in pancreatic cancer research. Proteomics 2011, 11:816-828.
4. Dalla Pozza E., Fiorini C., Dando I., Menegazzi M., Sgarbossa A., Costanzo C., Palmieri M., Donadelli M. Role of mitochondrial uncoupling protein 2 in cancer cell resistance to gemcitabine. Biochim. Biophys. Acta 2012, 1823:1856-1863.
5. Donadelli M., Dalla Pozza E., Scupoli M.T., Costanzo C., Scarpa A., Palmieri M. Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis. Biochim. Biophys. Acta 2009, 1793:273-280.
6. Dalla Pozza E., Donadelli M., Costanzo C., Zaniboni T., Dando I., Franchini M., Arpicco S., Scarpa A., Palmieri M. Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives. Free Radic. Biol. Med. 2011, 50:926-933.
7. Cecconi D., Donadelli M., Dalla Pozza E., Rinalducci S., Zolla L., Scupoli M.T., Righetti P.G., Scarpa A., Palmieri M. Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics 2009, 9:1952-1966.
8. Kondo Y., Kondo S. Autophagy and cancer therapy. Autophagy 2006, 2:85-90.
9. Amelio I., Melino G., Knight R.A. Cell death pathology: cross-talk with autophagy and its clinical implications. Biochem. Biophys. Res. Commun. 2011, 414:277-281.
10. Mizushima N. Physiological functions of autophagy. Curr. Top. Microbiol. Immunol. 2009, 335:71-84.
11. Dando I., Fiorini C., Pozza E.D., Padroni C., Costanzo C., Palmieri M., Donadelli M. UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells. Biochim. Biophys. Acta 2013, 1833:672-679.
12. Pattingre S., Levine B. Bcl-2 inhibition of autophagy: a new route to cancer?. Cancer Res. 2006, 66:2885-2888.
13. Maiuri M.C., Tasdemir E., Criollo A., Morselli E., Vicencio J.M., Carnuccio R., Kroemer G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ. 2009, 16:87-93.
14. D'Alessio G. New and cryptic biological messages from RNases. Trends Cell Biol. 1993, 3:106-109.
15. Arnold U. Therapeutic potential of RNases. Curr. Pharm. Biotechnol. 2008, 9:134.
16. Fang E.F., Ng T.B. Ribonucleases of different origins with a wide spectrum of medicinal applications. Biochim. Biophys. Acta 2011, 1815:65-74.
17. Arnold U. Aspects of the cytotoxic action of ribonucleases. Curr. Pharm. Biotechnol. 2008, 9:161-168.
18. Castro J., Ribo M., Benito A., Vilanova M. Mini-review: nucleus-targeted ribonucleases as antitumor drugs. Curr. Med. Chem. 2013, 20:1225-1231.
19. Gotte G., Laurents D.V., Merlino A., Picone D., Spadaccini R. Structural and functional relationships of natural and artificial dimeric bovine ribonucleases: new scaffolds for potential antitumor drugs. FEBS Lett. 2013, 587:3601-3608.
20. Spadaccini R., Ercole C., Gentile M.A., Sanfelice D., Boelens R., Wechselberger R., Batta G., Bernini A., Niccolai N., Picone D. NMR studies on structure and dynamics of the monomeric derivative of BS-RNase: new insights for 3D domain swapping. PLoS One 2012, 7:e29076.
21. Bennett M.J., Choe S., Eisenberg D. Domain swapping: entangling alliances between proteins. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:3127-3131.
22. Piccoli R., Tamburrini M., Piccialli G., Di Donato A., Parente A., D'Alessio G. The dual-mode quaternary structure of seminal RNase. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:1870-1874.
23. Kobe B., Deisenhofer J. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A. J. Mol. Biol. 1996, 264:1028-1043.
24. Sica F., Di Fiore A., Merlino A., Mazzarella L. Structure and stability of the non-covalent swapped dimer of bovine seminal ribonuclease: an enzyme tailored to evade ribonuclease protein inhibitor. J. Biol. Chem. 2004, 279:36753-36760.
25. Kim J.S., Soucek J., Matousek J., Raines R.T. Mechanism of ribonuclease cytotoxicity. J. Biol. Chem. 1995, 270:31097-31102.
26. Crestfield A.M., Stein W.H., Moore S. On the aggregation of bovine pancreatic ribonuclease. Arch. Biochem. Biophys. 1962, (Suppl. 1):217-222.
27. Liu Y., Hart P.J., Schlunegger M.P., Eisenberg D. The crystal structure of a 3D domain-swapped dimer of RNase A at a 2.1-A resolution. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3437-3442.
28. Liu Y., Gotte G., Libonati M., Eisenberg D. A domain-swapped RNase A dimer with implications for amyloid formation. Nat. Struct. Biol. 2001, 8:211-214.
29. Ercole C., Colamarino R.A., Pizzo E., Fogolari F., Spadaccini R., Picone D. Comparison of the structural and functional properties of RNase A and BS-RNase: a stepwise mutagenesis approach. Biopolymers 2009, 91:1009-1017.
30. Liu Y., Gotte G., Libonati M., Eisenberg D. Structures of the two 3D domain-swapped RNase A trimers. Protein Sci. 2002, 11:371-380.
31. Cozza G., Moro S., Gotte G. Elucidation of the ribonuclease a aggregation process mediated by 3D domain swapping: a computational approach reveals possible new multimeric structures. Biopolymers 2008, 89:26-39.
32. Gotte G., Laurents D.V., Libonati M. Three-dimensional domain-swapped oligomers of ribonuclease A: identification of a fifth tetramer, pentamers and hexamers, and detection of trace heptameric, octameric and nonameric species. Biochim. Biophys. Acta 2006, 1764:44-54.
33. Libonati M., Gotte G. Oligomerization of bovine ribonuclease A: structural and functional features of its multimers. Biochem. J. 2004, 380:311-327.
34. Matousek J., Gotte G., Pouckova P., Soucek J., Slavik T., Vottariello F., Libonati M. Antitumor activity and other biological actions of oligomers of ribonuclease A. J. Biol. Chem. 2003, 278:23817-23822.
35. Vottariello F., Costanzo C., Gotte G., Libonati M. "Zero-length" dimers of ribonuclease A: further characterization and no evidence of cytotoxicity. Bioconjug. Chem. 2010, 21:635-645.
36. Gotte G., Testolin L., Costanzo C., Sorrentino S., Armato U., Libonati M. Cross-linked trimers of bovine ribonuclease A: activity on double-stranded RNA and antitumor action. FEBS Lett. 1997, 415:308-312.
37. Libonati M., Gotte G., Vottariello F. A novel biological actions acquired by ribonuclease through oligomerization. Curr. Pharm. Biotechnol. 2008, 9:200-209.
38. Gotte G., Mahmoud Helmy A., Ercole C., Spadaccini R., Laurents D.V., Donadelli M., Picone D. Double domain swapping in bovine seminal RNase: formation of distinct N- and C-swapped tetramers and multimers with increasing biological activities. PLoS One 2012, 7:e46804.
39. D'Errico G., Ercole C., Lista M., Pizzo E., Falanga A., Galdiero S., Spadaccini R., Picone D. Enforcing the positive charge of N-termini enhances membrane interaction and antitumor activity of bovine seminal ribonuclease. Biochim. Biophys. Acta 2011, 1808:3007-3015.
40. Avitabile F., Alfano C., Spadaccini R., Crescenzi O., D'Ursi A.M., D'Alessio G., Tancredi T., Picone D. The swapping of terminal arms in ribonucleases: comparison of the solution structure of monomeric bovine seminal and pancreatic ribonucleases. Biochemistry 2003, 42:8704-8711.
41. Picone D., Di Fiore A., Ercole C., Franzese M., Sica F., Tomaselli S., Mazzarella L. The role of the hinge loop in domain swapping. The special case of bovine seminal ribonuclease. J. Biol. Chem. 2005, 280:13771-13778.
42. Adinolfi S., Piccoli R., Sica F., Mazzarella L. BS-RNase tetramers: an example of domain-swapped oligomers. FEBS Lett. 1996, 398:326-332.
43. Lopez-Alonso J.P., Gotte G., Laurents D.V. Kinetic analysis provides insight into the mechanism of ribonuclease A oligomer formation. Arch. Biochem. Biophys. 2009, 489:41-47.
44. Donadelli M., Costanzo C., Beghelli S., Scupoli M.T., Dandrea M., Bonora A., Piacentini P., Budillon A., Caraglia M., Scarpa A., Palmieri M. Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine. Biochim. Biophys. Acta 2007, 1773:1095-1106.
45. Zetterberg A., Larsson O. Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:5365-5369.
46. Libonati M. Molecular aggregates of ribonucleases. Some enzymatic properties. Ital. J. Biochem. 1969, 18:407-417.
47. Mizushima N., Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011, 147:728-741.
48. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol. Cell 2010, 40:280-293.
49. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368:651-662.
50. Levine B. Cell biology: autophagy and cancer. Nature 2007, 446:745-747.
51. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 2012, 12:401-410.
52. Fiorini C., Menegazzi M., Padroni C., Dando I., Dalla Pozza E., Gregorelli A., Costanzo C., Palmieri M., Donadelli M. Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. Apoptosis 2013, 18:337-346.
53. Donadelli M., Dando I., Zaniboni T., Costanzo C., Dalla Pozza E., Scupoli M.T., Scarpa A., Zappavigna S., Marra M., Abbruzzese A., Bifulco M., Caraglia M., Palmieri M. Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism. Cell Death Dis. 2011, 2:e152.
54. Dando I., Donadelli M., Costanzo C., Dalla Pozza E., D'Alessandro A., Zolla L., Palmieri M. Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells. Cell Death Dis. 2013, 4:e664.
55. Chakrabarti A., Ghosh P.K., Banerjee S., Gaughan C., Silverman R.H. RNase L triggers autophagy in response to viral infections. J. Virol. 2012, 86:11311-11321.
56. Siddiqui M.A., Malathi K. RNase L induces autophagy via c-Jun N-terminal kinase and double-stranded RNA-dependent protein kinase signaling pathways. J. Biol. Chem. 2012, 287:43651-43664.
57. Pattingre S., Tassa A., Qu X., Garuti R., Liang X.H., Mizushima N., Packer M., Schneider M.D., Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005, 122:927-939.
58. Chu C.T., Zhu J., Dagda R. Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death. Autophagy 2007, 3:663-666.
59. Libonati M., Sorrentino S. Revisiting the action of bovine ribonuclease A and pancreatic-type ribonucleases on double-stranded RNA. Mol. Cell. Biochem. 1992, 117:139-151.
60. Merlino A., Ercole C., Picone D., Pizzo E., Mazzarella L., Sica F. The buried diversity of bovine seminal ribonuclease: shape and cytotoxicity of the swapped non-covalent form of the enzyme. J. Mol. Biol. 2008, 376:427-437.
61. Naddeo M., Vitagliano L., Russo A., Gotte G., D'Alessio G., Sorrentino S. Interactions of the cytotoxic RNase A dimers with the cytosolic ribonuclease inhibitor. FEBS Lett. 2005, 579:2663-2668.